For around 30% of all bowel cancer cases diagnosed there is a family history, hereditary contribution or a combination of both.
It is a disease that affects men and women of all ages, and its impact is felt not just by those diagnosed with the disease, but also by their loved ones.
A new grant secured by the Lawrence Penn Chair of Bowel Cancer Research laboratory from the Cancer Institute NSW will enable further investigation into the prognostic contribution of immune cell infiltration in rectal cancer.
Bowel cancer is the second most commonly diagnosed cancer in Aussie women, claiming the lives of almost 2,500 wives, mothers, sisters, daughters, aunts, nieces and girlfriends in Australia every year.
Bowel cancer in pregnancy is distinct from bowel cancer in the general population.
As the presenting features of bowel cancer can overlap with those of pregnancy itself, pregnant patients typically present with advanced bowel cancer.
This is usually a result of delayed diagnosis, and often leads to a poorer prognosis at diagnosis.
Bowel cancer is the second most commonly diagnosed cancer in women, after breast cancer, and the third leading cause of cancer deaths in Australian women after lung and breast cancer.
It is a common misconception that bowel cancer is an old man’s disease. Yet the reality is, bowel cancer affects women of all ages, and almost half of all people diagnosed with bowel cancer in Australia each year are women.
But the good news is that bowel cancer is treatable and beatable if detected early.
That’s why it is so important for Aussie women to be Champions of their own health – to be aware and be active when it comes to bowel cancer.